Irisin

Irisin is a small secreted protein classified as a myokine, meaning a hormone-like molecule released by skeletal muscle ^[1]. It is not taken as a supplement or drug but is produced naturally within the body, chiefly in response to exercise ^[1]. Irisin is not made directly from its own gene; instead it is cut from a larger membrane protein called FNDC5, which sits in the surface of muscle cells and, when cleaved, releases the irisin portion into the bloodstream ^[1].

Irisin was discovered and named in 2012 by a team led by Bruce Spiegelman, who reported in the journal Nature that exercise drives muscle to secrete this hormone and that it converts white fat toward a brown-fat-like, heat-producing state ^[1]. The initial finding generated enormous interest because it offered a molecular explanation for some of the metabolic benefits of exercise and raised the possibility of a treatment for obesity and type 2 diabetes ^[1]. Subsequent research extended its proposed roles to bone, where it may support bone density, and to the brain, where it has been connected to neurotrophic signaling and the cognitive effects of physical activity ^[4].

Irisin has also been one of the more controversial molecules in metabolic science ^[2]. Early doubts arose because the human FNDC5 gene has an unusual, non-standard start codon that some researchers argued would prevent efficient production of the protein, and because many commercial antibody-based tests for irisin were found to lack specificity, casting doubt on published blood measurements ^[2]. In response, investigators used tandem mass spectrometry with precisely defined reference peptides to show that human irisin does in fact circulate and that its levels rise with exercise, a result offered as strong confirmation of its existence ^[2]. Studies have also revealed added complexity, such as evidence that fat tissue secretes the irisin precursor too, so that irisin may function as both a myokine and an adipokine ^[3].

Irisin remains a subject of active investigation rather than an approved therapy, and much of the evidence for its metabolic, skeletal, and cognitive effects comes from cell and animal experiments ^[4]. Its full physiological importance in humans, the receptor it engages, and its potential as a target for treating metabolic or age-related disease are still being worked out ^[1][4]. For now it is best understood as a naturally occurring exercise hormone under study, not as a compound that is administered ^[1].

There's no established supplement, so there's no meaningful human safety profile for taking irisin. As an endogenous hormone produced by exercise, higher levels from training are simply normal physiology. Any injectable or product claiming to be irisin should be treated with heavy skepticism.